Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Study Published: BioDiem Ltd - Product Pipeline Review - 2014


Print article Print article
2014-02-25 12:25:32 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "BioDiem Ltd - Product Pipeline Review - 2014" provides data on the BioDiem Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, BioDiem Ltd's corporate website, SEC filings, investor presentations and featured press releases, both from BioDiem Ltd and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/778152_biodiem_ltd_product_pipeline_review_2 ..

Report Scope

* BioDiem Ltd - Brief BioDiem Ltd overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline

of BioDiem Ltd human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of BioDiem Ltd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the BioDiem Ltd's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate BioDiem Ltd's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of BioDiem Ltd in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the BioDiem Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with BioDiem Ltd.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of BioDiem Ltd and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
List of Tables
List of Figures
BioDiem Ltd Snapshot
BioDiem Ltd Overview
Key Information
Key Facts
BioDiem Ltd - Research and Development Overview
Key Therapeutic Areas
BioDiem Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
BioDiem Ltd - Pipeline Products Glance
BioDiem Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
BioDiem Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
BioDiem Ltd - Drug Profiles
Live Attenuated Influenza Vaccine
Product Description
Mechanism of Action
R&D Progress
BDM-E
Product Description
Mechanism of Action
R&D Progress
BDM-I
Product Description
Mechanism of Action
R&D Progress
Hepatitis B Vaccine
Product Description
Mechanism of Action
R&D Progress
Hepatitis D Vaccine
Product Description
Mechanism of Action
R&D Progress
BioDiem Ltd - Pipeline Analysis
BioDiem Ltd - Pipeline Products by Therapeutic Class
BioDiem Ltd - Pipeline Products by Route of Administration
BioDiem Ltd - Pipeline Products by Molecule Type
BioDiem Ltd - Recent Pipeline Updates
BioDiem Ltd - Dormant Projects
BioDiem Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
BioDiem Ltd, Key Information
BioDiem Ltd, Key Facts
BioDiem Ltd - Pipeline by Indication, 2014
BioDiem Ltd - Pipeline by Stage of Development, 2014
BioDiem Ltd - Monotherapy Products in Pipeline, 2014
BioDiem Ltd - Phase II, 2014
BioDiem Ltd - Phase I, 2014
BioDiem Ltd - Preclinical, 2014
BioDiem Ltd - Discovery, 2014
BioDiem Ltd - Pipeline by Therapeutic Class, 2014
BioDiem Ltd - Pipeline by Route of Administration, 2014
BioDiem Ltd - Pipeline by Molecule Type, 2014
BioDiem Ltd - Recent Pipeline Updates, 2014
BioDiem Ltd - Dormant Developmental Projects,2014
BioDiem Ltd, Subsidiaries

List of Figures
BioDiem Ltd - Pipeline by Top 10 Indication, 2014
BioDiem Ltd - Pipeline by Stage of Development, 2014
BioDiem Ltd - Monotherapy Products in Pipeline, 2014
BioDiem Ltd - Pipeline by Top 10 Therapeutic Class, 2014
BioDiem Ltd - Pipeline by Top 10 Molecule Type, 2014

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com